The use of machine learning for the identification of peripheral artery disease and future mortality risk

Journal of Vascular Surgery

Volumn 64, Issue 5, 2016, Pages 1515-1522.e3

  Ross, Elsie Gyang ^a   Shah, Nigam H ^b   Dalman, Ronald L ^a   Nead, Kevin T ^c   Cooke, John P ^d   Leeper, Nicholas J ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MACHINE LEARNING; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RISK; OBSERVATIONAL STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL ACTIVITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOM FOREST; SOCIAL STATUS; SUPERVISED MACHINE LEARNING; ALGORITHM; AREA UNDER THE CURVE; CLASSIFICATION; DATA MINING; DECISION SUPPORT SYSTEM; FACTUAL DATABASE; GENETICS; GENOMICS; MORTALITY; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

AGED; ALGORITHMS; ANKLE BRACHIAL INDEX; AREA UNDER CURVE; CORONARY ANGIOGRAPHY; DATA MINING; DATABASES, FACTUAL; DECISION SUPPORT TECHNIQUES; FEMALE; GENOMICS; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MACHINE LEARNING; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE;

EID: 84971612092     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2016.04.026     Document Type: Article

References (45)

1. 1 Garraway, L.A., Verweij, J., Ballman, K.V., Precision oncology: an overview. J Clin Oncol 31 (2013), 1803–1805.
2. 2 Bielinski, S.J., Olson, J.E., Pathak, J., Weinshilboum, R.M., Wang, L., Lyke, K.J., et al. Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time—using genomic data to individualize treatment protocol. Mayo Clin Proc 89 (2014), 25–33.
3. 3 Calculate your Ubble age. UK Longevity Explorer (UbbLE); 2016. Available at: http://www.ubble.co.uk/. Accessed February 1, 2016.
4. 4 Ganna, A., Ingelsson, E., 5 year mortality predictors in 498,103 UK biobank participants: a prospective population-based study. Lancet 386 (2015), 533–540.
5. 5 Parikh, R.B., Kakad, M., Bates, D.W., Integrating predictive analytics into high-value care: the dawn of precision delivery. JAMA 315 (2016), 651–652.
6. 6 Fowkes, F.G., Rudan, D., Rudan, I., Aboyans, V., Denenberg, J.O., McDermott, M.M., et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382 (2013), 1329–1340.
7. 7 Alberts, M.J., Bhatt, D.L., Mas, J.L., Ohman, E.M., Hirsch, A.T., Röther, J., et al. Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. Eur Heart J 30 (2009), 2318–2326.
8. 8 Hirsch, A.T., Criqui, M.H., Treat-Jacobson, D., Regensteiner, J.G., Creager, M.A., Olin, J.W., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286 (2001), 1317–1324.
9. 9 Chang, P., Nead, K.T., Olin, J.W., Cooke, J.P., Leeper, N.J., Clinical and socioeconomic factors associated with unrecognized peripheral artery disease. Vasc Med 19 (2014), 289–296.
10. 10 Sadrzadeh Rafie, A.H., Stefanick, M.L., Sims, S.T., Phan, T., Higgins, M., Gabriel, A., et al. Sex differences in the prevalence of peripheral artery disease in patients undergoing coronary catheterization. Vasc Med 15 (2010), 443–450.
11. 11 Nead, K.T., Cooke, J.P., Olin, J.W., Leeper, N.J., Alternative ankle-brachial index method identifies additional at-risk individuals. J Am Coll Cardiol 62 (2013), 553–559.
12. 12 Zou, H., Hastie, T., Regularization and variable selection via the elastic net. J R Stat Soc Series B Stat Methodol 67 (2005), 301–320.
13. 13 Breiman, L., Random forests. Machine Learning 45 (2001), 5–32.
14. 14 Kuhn, M., Johnson, K., Applied predictive modeling. 2013, Springer, New York.
15. 15 R Core Team. R: a language and environment for statistical computing. 2015, R Foundation for Statistical Computing, Vienna, Austria.
16. 16 Steyerberg, E.W., Vickers, A.J., Cook, N.R., Gerds, T., Gonen, M., Obuchowski, N., et al. Assessing the performance of prediction models: a framework for some traditional and novel measures. Epidemiology 21 (2010), 128–138.
17. 17 Hosmer, D.W., Lemeshow, S., Goodness of fit tests for the multiple logistic regression model. Commun Stat Theory Methods 9 (1980), 1043–1069.
18. 18 Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.C., et al. pROC: an open-source package for R and S+ to analyze and compare roc curves. BMC Bioinformatics, 12, 2011, 77.
19. 19 Pencina, M.J., Steyerberg, E.W., D'Agostino, R.B., Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30 (2011), 11–21.
20. 20 Lindstrom, J., Tuomilehto, J., The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26 (2003), 725–731.
21. 21 Wilson, P.W., D'Agostino, R.B., Levy, D., Belanger, A.M., Silbershatz, H., Kannel, W.B., Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998), 1837–1847.
22. 22 Gail, M.H., Brinton, L.A., Byar, D.P., Corle, D.K., Green, S.B., Schairer, C., et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81 (1989), 1879–1886.
23. 23 Ramsay, S.E., Morris, R.W., Whincup, P.H., Papacosta, A.O., Thomas, M.C., Wannamethee, S.G., Prediction of coronary heart disease risk by Framingham and SCORE risk assessments varies by socioeconomic position: results from a study in British men. Eur J Cardiovasc Prev Rehabil 18 (2011), 186–193.
24. 24 Arts, E.E., Popa, C., Den Broeder, A.A., Semb, A.G., Toms, T., Kitas, G.D., et al. Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. Ann Rheum Dis 74 (2015), 668–674.
25. 25 Tillin, T., Hughes, A.D., Whincup, P., Mayet, J., Sattar, N., McKeigue, P.M., et al. Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a U.K. tri-ethnic prospective cohort study (SABRE–Southall And Brent REvisited). Heart 100 (2014), 60–67.
26. 26 Murphy, T.P., Dhangana, R., Pencina, M.J., Sr, D'Agostino RB., Ankle-brachial index and cardiovascular risk prediction: an analysis of 11,594 individuals with 10-year follow-up. Atherosclerosis 220 (2012), 160–167.
27. 27 Liabeuf, S., Desjardins, L., Diouf, M., Temmar, M., Renard, C., Choukroun, G., et al. The addition of vascular calcification scores to traditional risk factors improves cardiovascular risk assessment in patients with chronic kidney disease. PLoS One, 10, 2015, e0131707.
28. 28 Kadowaki, S., Shishido, T., Honda, Y., Narumi, T., Otaki, Y., Kinoshita, D., et al. Additive clinical value of serum brain-derived neurotrophic factor for prediction of chronic heart failure outcome. Heart Vessels 31 (2016), 535–544.
29. 29 Wang, T.J., Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Circulation 123 (2011), 551–565.
30. 30 Duval, S., Massaro, J.M., Jaff, M.R., Boden, W.E., Alberts, M.J., Califf, R.M., et al. An evidence-based score to detect prevalent peripheral artery disease (PAD). Vasc Med 17 (2012), 342–351.
31. 31 Jonnagaddala, J., Liaw, S.T., Ray, P., Kumar, M., Chang, N.W., Dai, H.J., Coronary artery disease risk assessment from unstructured electronic health records using text mining. J Biomed Inform 58:Suppl (2015), S203–S210.
32. 32 Leeper, N.J., Bauer-Mehren, A., Iyer, S.V., Lependu, P., Olson, C., Shah, N.H., Practice-based evidence: profiling the safety of cilostazol by text-mining of clinical notes. PLoS One, 8, 2013, e63499.
33. 33 Finlay, G.D., Rothman, M.J., Smith, R.A., Measuring the modified early warning score and the Rothman index: advantages of utilizing the electronic medical record in an early warning system. J Hosp Med 9 (2014), 116–119.
34. 34 Henry, K.E., Hager, D.N., Pronovost, P.J., Saria, S., A targeted real-time early warning score (TREWScore) for septic shock. Sci Transl Med, 7, 2015, 299ra122.
35. 35 Jung, K., Covington, S., Sen, C.K., Januszyk, M., Kirsner, R.S., Gurtner, G.C., et al. Rapid identification of slow healing wounds. Wound Repair Regen 24 (2016), 181–188.
36. 36 Weiss, J.C., Natarajan, S., Peissig, P.L., McCarty, C.A., Page, D., Machine learning for personalized medicine: predicting primary myocardial infarction from electronic health records. AI Magazine, 33, 2012, 33.
37. 37 Jung, K., Shah, N.H., Implications of non-stationarity on predictive modeling using EHRs. J Biomed Inform 58 (2015), 168–174.
38. 38 Celi, L.A., Tang, R.J., Villarroel, M.C., Davidzon, G.A., Lester, W.T., Chueh, H.C., A clinical database-driven approach to decision support: predicting mortality among patients with acute kidney injury. J Healthc Eng 2 (2011), 97–110.
39. 39 Criqui, M.H., Aboyans, V., Epidemiology of peripheral artery disease. Circ Res 116 (2015), 1509–1526.
40. 40 McDermott, M.M., Kerwin, D.R., Liu, K., Martin, G.J., O'Brien, E., Kaplan, H., et al. Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice*. J Gen Intern Med 16 (2001), 384–390.
41. 41 Nikolsky, E., Mehran, R., Mintz, G.S., Dangas, G.D., Lansky, A.J., Aymong, E.D., et al. Impact of symptomatic peripheral arterial disease on 1-year mortality in patients undergoing percutaneous coronary interventions. J Endovasc Ther 11 (2004), 60–70.
42. 42 Hildick-Smith, D.J., Walsh, J.T., Lowe, M.D., Stone, D.L., Schofield, P.M., Shapiro, L.M., et al. Coronary angiography in the presence of peripheral vascular disease: femoral or brachial/radial approach?. Catheter Cardiovasc Interv 49 (2000), 32–37.
43. 43 Olin, J.W., Sealove, B.A., Peripheral artery disease: current insight into the disease and its diagnosis and management. Mayo Clin Proc 85 (2010), 678–692.
44. 44 Bonaca, M.P., Creager, M.A., Pharmacological treatment and current management of peripheral artery disease. Circ Res 116 (2015), 1579–1598.
45. 45 Kent, K.C., Zwolak, R.M., Egorova, N.N., Riles, T.S., Manganaro, A., Moskowitz, A.J., et al. Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg 52 (2010), 539–548.